SanBio Company Cash Flow Statement

Financials in millions JPY. Fiscal year is February - January.

Millions JPY. Fiscal year is Feb - Jan.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Net Income	-4,291	-3,010	-2,542	-4,697	-4,560
Depreciation & Amortization	8	9	14	24	132
Loss (Gain) From Sale of Assets	-	-2	-30	-1	10
Other Operating Activities	34	-18	-1	-90	-186
Change in Inventory	-	-	-	510	3
Change in Accounts Payable	-65	-172	-93	-241	78
Change in Other Net Operating Assets	554	-410	-2,113	-2,939	-2,023
Operating Cash Flow	-3,760	-3,603	-4,765	-7,434	-6,546
Capital Expenditures	-32	-4	-11	-7	-42
Sale of Property, Plant & Equipment	1	-	35	1	-
Sale (Purchase) of Intangibles	-	-	-43	-	-14
Investment in Securities	-200	-	-	-	-
Other Investing Activities	-	-	-	-4	-10
Investing Cash Flow	-231	-4	-19	-10	-66
Long-Term Debt Issued	1,080	-	-	-	-
Total Debt Issued	1,080	-	-	-	-
Short-Term Debt Repaid	-	-	-	-	-500
Long-Term Debt Repaid	-268	-268	-268	-1,592	-975
Total Debt Repaid	-268	-268	-268	-1,592	-1,475
Net Debt Issued (Repaid)	812	-268	-268	-1,592	-1,475
Issuance of Common Stock	15,195	2,372	2,651	11,055	3
Other Financing Activities	-45	-13	-13	-18	-23
Financing Cash Flow	15,962	2,091	2,370	9,445	-1,495
Foreign Exchange Rate Adjustments	-8	-20	128	116	185
Miscellaneous Cash Flow Adjustments	-1	-	1	1	-1
Net Cash Flow	11,962	-1,536	-2,285	2,118	-7,923
Free Cash Flow	-3,792	-3,607	-4,776	-7,441	-6,588
Free Cash Flow Per Share	-51.86	-52.38	-73.11	-128.47	-127.21
Cash Interest Paid	5	8	10	25	45
Cash Income Tax Paid	-3	16	-	89	187
Levered Free Cash Flow	-2,469	-2,302	-3,316	-4,506	-4,274
Unlevered Free Cash Flow	-2,446	-2,297	-3,310	-4,490	-4,247
Change in Working Capital	489	-582	-2,206	-2,670	-1,942

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.